2
1
1
|
|
Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancerInternational Journal of Cancer, 2020, 146 (11), pp.3147-3159. ⟨10.1002/ijc.32920⟩ |
|
|
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?International Journal of Molecular Sciences, 2019, 20 (18), pp.4584. ⟨10.3390/ijms20184584⟩ |
|
|
Microbial markers in colorectal cancer detection and/or prognosisWorld Journal of Gastroenterology, 2018, 24 (22), pp.2327 - 2347. ⟨10.3748/wjg.v24.i22.2327⟩ |
PKS-ISLAND POSITIVE E. COLI AS MARKER OF NEGATIVE RESPONSE TO ANTI-PD1 THERAPY IN COLORECTAL CANCERFrance, Patent n° : WO2019EP84487 20191210. 2019 |